Need professional-grade analysis? Visit stockanalysis.com
$258.57M
N/A
90
N/A
CapsoVision, Inc. Common Stock (CV) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at $8.69, up 26.49% from the previous close.
Over the past year, CV has traded between a low of $3.50 and a high of $14.42. The stock has gained 148.3% over this period. It is currently 39.7% below its 52-week high.
CapsoVision, Inc. Common Stock has a market capitalization of $258.57M.
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. It offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). The company also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoAccess, a Capsule data access system; CapsoView, a data access reading device for viewing capsule videos; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. It serves gastrointestinal medical practices, clinics, and hospitals. The company sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.